TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biobact AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
168
|
930 |
| Financial expenses |
7
|
52
|
52 |
| Earnings before taxes |
-81
|
3,244
|
-1,092 |
| EBITDA |
-124
|
-962
|
-961 |
| Total assets |
2,409
|
3,776
|
1,868 |
| Current assets |
1,470
|
3,776
|
736 |
| Current liabilities |
36
|
1,335
|
1,789 |
| Equity capital |
2,374
|
2,441
|
-873 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
1
|
2
|
4 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
98.5%
|
64.6%
|
-46.7% |
| Turnover per employee |
0
|
84
|
232 |
| Profit as a percentage of turnover |
1931.0%
|
-117.4% | |
| Return on assets (ROA) |
-3.1%
|
87.3%
|
-55.7% |
| Current ratio |
4083.3%
|
282.8%
|
41.1% |
| Return on equity (ROE) |
-3.4%
|
132.9%
|
125.1% |
| Change turnover |
-169
|
-687
|
-736 |
| Change turnover % |
-100%
|
-80%
|
-44% |
| Chg. No. of employees |
-1
|
-2
|
-1 |
| Chg. No. of employees % |
-50%
|
-50%
|
-20% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.